Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297173676> ?p ?o ?g. }
- W4297173676 abstract "Surgical aortic valve replacement (SAVR) is the current treatment of choice for good surgical candidates with moderate to severe symptomatic aortic stenosis (AS). As transcatheter aortic valvular replacement (TAVR) has shown an improved one and two-year all-cause mortality, it has been chosen for moderately symptomatic severe AS patients. The purpose of this review was to perform a clinical comparison of TAVR vs. SAVR and to analyze the Health Index Factor (HIF) that makes TAVR a treatment of choice in asymptomatic AS patients. An extensive literature search of PubMed, Cochrane, and Embase databases was performed using the keywords Aortic stenosis, SAVR, TAVR, and Asymptomatic. A total of 45 prospective randomized clinical trials in the English language that were published from the year 2000 onwards were included in the final analysis. It has been found that 59.3% of asymptomatic AS patients are likely to die in the next five years without proactive treatment. Multiple studies have proven that early intervention with aortic valve replacement is superior to conservative treatment in severe asymptomatic AS; however, the choice between SAVR and TAVR is not well established. The NOTION Trial, SURTAVI Trail, and PARTNER 3 study have shown the non-inferiority of TAVR over SAVR, during one-year follow-up for low surgical risk patients. Evolut Low-Risk study and Early TAVR are the only two prospective studies performed to date that have enrolled patients with asymptomatic severe AS. The Evolut Trial demonstrated no difference in all-cause mortality at 30 days (1.3% vs. 4.8%. p=0.23), and 12 days (1.3% vs. 6.5%, p=0.11). Additionally, TAVR also decreases the risk of post-procedural atrial fibrillation, acute kidney injury (AKI), and rehospitalization, and leads to significant improvement in the mean trans-aortic pressure gradient. TAVR also showed marked improvement in the 30-day Quality of Life (QOL) index, where SAVR did not report any significant change in the QOL index. However, the official recommendations of Early TAVR are still awaited. TAVR has consistently shown a statistically non-significant difference in case mortality, risk of stroke, and rehospitalization with moderate to high surgical risk patients whereby recent initial trials have shown significant improvement in the QOL index and hemodynamic index for patients with asymptomatic disease. More extensive studies are required to prove the risk stratifications, long-term outcomes, and clinical characteristics that would make TAVR a preferred intervention in asymptomatic patients." @default.
- W4297173676 created "2022-09-27" @default.
- W4297173676 creator A5009623210 @default.
- W4297173676 creator A5020296929 @default.
- W4297173676 creator A5029786244 @default.
- W4297173676 creator A5037083869 @default.
- W4297173676 creator A5041237666 @default.
- W4297173676 creator A5059573414 @default.
- W4297173676 creator A5084083757 @default.
- W4297173676 date "2022-09-24" @default.
- W4297173676 modified "2023-10-05" @default.
- W4297173676 title "The Role of Transcatheter Aortic Valve Replacement in Asymptomatic Aortic Stenosis: A Feasibility Analysis" @default.
- W4297173676 cites W136720192 @default.
- W4297173676 cites W144098477 @default.
- W4297173676 cites W1530912040 @default.
- W4297173676 cites W173091792 @default.
- W4297173676 cites W1968265535 @default.
- W4297173676 cites W1969962485 @default.
- W4297173676 cites W1974432041 @default.
- W4297173676 cites W1981040027 @default.
- W4297173676 cites W1984026532 @default.
- W4297173676 cites W1988482331 @default.
- W4297173676 cites W1989672363 @default.
- W4297173676 cites W2037537187 @default.
- W4297173676 cites W2038578901 @default.
- W4297173676 cites W2059864560 @default.
- W4297173676 cites W2067905792 @default.
- W4297173676 cites W2072516154 @default.
- W4297173676 cites W2081961859 @default.
- W4297173676 cites W2082138617 @default.
- W4297173676 cites W2089247686 @default.
- W4297173676 cites W2094265494 @default.
- W4297173676 cites W2096204162 @default.
- W4297173676 cites W2108007523 @default.
- W4297173676 cites W2121399917 @default.
- W4297173676 cites W2121588050 @default.
- W4297173676 cites W2122694177 @default.
- W4297173676 cites W2131958422 @default.
- W4297173676 cites W2132585880 @default.
- W4297173676 cites W2136587281 @default.
- W4297173676 cites W2165258820 @default.
- W4297173676 cites W2201168640 @default.
- W4297173676 cites W2203826914 @default.
- W4297173676 cites W2290072217 @default.
- W4297173676 cites W2293311438 @default.
- W4297173676 cites W2300144227 @default.
- W4297173676 cites W2310246866 @default.
- W4297173676 cites W2322310887 @default.
- W4297173676 cites W2324073140 @default.
- W4297173676 cites W2334341306 @default.
- W4297173676 cites W2343625122 @default.
- W4297173676 cites W2346006474 @default.
- W4297173676 cites W2515126756 @default.
- W4297173676 cites W2589128496 @default.
- W4297173676 cites W2596188051 @default.
- W4297173676 cites W2605849388 @default.
- W4297173676 cites W2622285037 @default.
- W4297173676 cites W2740120589 @default.
- W4297173676 cites W2750139127 @default.
- W4297173676 cites W2751630023 @default.
- W4297173676 cites W2755361095 @default.
- W4297173676 cites W2781247464 @default.
- W4297173676 cites W2801311102 @default.
- W4297173676 cites W2894689197 @default.
- W4297173676 cites W2915464224 @default.
- W4297173676 cites W2921388585 @default.
- W4297173676 cites W2941855815 @default.
- W4297173676 cites W2960027137 @default.
- W4297173676 cites W2986128273 @default.
- W4297173676 cites W2986138421 @default.
- W4297173676 cites W3022029710 @default.
- W4297173676 cites W3041763021 @default.
- W4297173676 cites W3085015141 @default.
- W4297173676 cites W3092941779 @default.
- W4297173676 cites W3110765623 @default.
- W4297173676 cites W3165823418 @default.
- W4297173676 cites W3189838236 @default.
- W4297173676 cites W3195566978 @default.
- W4297173676 cites W3195842247 @default.
- W4297173676 cites W4200332843 @default.
- W4297173676 cites W4210557428 @default.
- W4297173676 cites W4220654332 @default.
- W4297173676 cites W4226428372 @default.
- W4297173676 cites W4250071522 @default.
- W4297173676 cites W4280591017 @default.
- W4297173676 doi "https://doi.org/10.7759/cureus.29522" @default.
- W4297173676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36312695" @default.
- W4297173676 hasPublicationYear "2022" @default.
- W4297173676 type Work @default.
- W4297173676 citedByCount "0" @default.
- W4297173676 crossrefType "journal-article" @default.
- W4297173676 hasAuthorship W4297173676A5009623210 @default.
- W4297173676 hasAuthorship W4297173676A5020296929 @default.
- W4297173676 hasAuthorship W4297173676A5029786244 @default.
- W4297173676 hasAuthorship W4297173676A5037083869 @default.
- W4297173676 hasAuthorship W4297173676A5041237666 @default.
- W4297173676 hasAuthorship W4297173676A5059573414 @default.
- W4297173676 hasAuthorship W4297173676A5084083757 @default.
- W4297173676 hasBestOaLocation W42971736761 @default.
- W4297173676 hasConcept C126322002 @default.